Pseudomonas aeruginosa found in soil, water and vegetations and sometimes in respiratory equipments, sinks and water taps, even in cleaning solutions, is an important nosocomial pathogen, specially when patient is immunocompromized and bed-ridden for long period.
Antipseudomonal drugs include piperacillin, mezlocillin and ticarcillin, ceftazidime, cefepime, aztreonam, imipenem, meropenem, tobramycin, gentamicin, amikacin, ciprofloxacin and levofloxacin. Unfortunately, due to development of resistance, the choice of drugs has been narrowed down. 16 The ESBL producers are those Gram negative bacteria which produce enzymes that hydrolyze cephalosporines and aztreonam. Presently, over 150 such enzymes have been identified. Imipenem/ meropenem alone or in combination with aminoglycoside are the drug of choice for severe infections by ESBL-producing bacteria. 12 However, cefepime, a fourth generation cephalosporin, may be useful in some of the cases.
Emergence of multidrug resistant (MDR) strains among common clinical microbes is now a great cause of concern throughout the world, including Bangladesh and its neighboring countries. [1] [2] [3] [4] [5] [6] It frequently causes treatment failure, prolonged period of hospital stay along with increased morbidity and mortality. 7-9 History of development of drug resistance is quite colourful. In early forties of the last century, penicillin came to the limelight and industries responded to public demand by producing penicillin soaps, penicillin mouthwashes, penicillin lozenges, penicillin throat sprays and what not. Alexander Fleming, the discoverer of penicillin cautioned: "the greatest possibility of evil in selfmedication is the use of too small doses so that instead of clearing up infection, the microbes are educated to resist penicillin". 10 Unfortunately, Fleming's words proved correct and within a few decades the world is shouldering a huge burden of emerging and re-emerging infectious diseases caused by multidrug resistant organisms. When vancomycin is contraindicated or resistant, treatment of severe infections caused by MRSA can be done by teicoplanin, linezolid, daptomycin or tigecycline. In less severe cases, oral agents such as linezolid, rifampicin + fusidic acid, rifampicin + fluoroquinolone, co-trimoxazole, clindamycin and minocycline can be used.
Among the MDR organisms, MRSA (Methicillin resistant
Enterococcus, a normal flora of lower GIT and genital tract, It is now obvious that the treatment for MDR organisms are becoming expensive and difficult. Antibiotics are to be prescribed only when needed. It is also important to pin-point the specific antibiotic which would suit patient the best. Time has come that health authorities should recognize the importance of establishing standard Microbiology laboratories for detection of MDR organisms in a hospital and in the community. But mere detection of the organisms would not be enough. Successful control of MDR needs improvements in hand hygiene, isolation of patients, enhanced environmental cleaning, active surveillance and education. It is hightime that our health authority would introduce a special module of infection control in the medical curriculum and make it a standard mandatory practice in all healthcare facilities.
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